217 related articles for article (PubMed ID: 27571165)
1. Protein arginine methyltransferase 1 is a novel regulator of MYCN in neuroblastoma.
Eberhardt A; Hansen JN; Koster J; Lotta LT; Wang S; Livingstone E; Qian K; Valentijn LJ; Zheng YG; Schor NF; Li X
Oncotarget; 2016 Sep; 7(39):63629-63639. PubMed ID: 27571165
[TBL] [Abstract][Full Text] [Related]
2. Protein arginine methyltransferase 5 is a key regulator of the MYCN oncoprotein in neuroblastoma cells.
Park JH; Szemes M; Vieira GC; Melegh Z; Malik S; Heesom KJ; Von Wallwitz-Freitas L; Greenhough A; Brown KW; Zheng YG; Catchpoole D; Deery MJ; Malik K
Mol Oncol; 2015 Mar; 9(3):617-27. PubMed ID: 25475372
[TBL] [Abstract][Full Text] [Related]
3. Downregulation of PRMT1 promotes the senescence and migration of a non-MYCN amplified neuroblastoma SK-N-SH cells.
Lee YJ; Chang WW; Chang CP; Liu TY; Chuang CY; Qian K; Zheng YG; Li C
Sci Rep; 2019 Feb; 9(1):1771. PubMed ID: 30741995
[TBL] [Abstract][Full Text] [Related]
4. MYCN and SNRPD3 cooperate to maintain a balance of alternative splicing events that drives neuroblastoma progression.
Salib A; Jayatilleke N; Seneviratne JA; Mayoh C; De Preter K; Speleman F; Cheung BB; Carter DR; Marshall GM
Oncogene; 2024 Jan; 43(5):363-377. PubMed ID: 38049564
[TBL] [Abstract][Full Text] [Related]
5. Prognostic significance of MYCN related genes in pediatric neuroblastoma: a study based on TARGET and GEO datasets.
Wang H; Wang X; Xu L; Zhang J; Cao H
BMC Pediatr; 2020 Jun; 20(1):314. PubMed ID: 32593299
[TBL] [Abstract][Full Text] [Related]
6. Deep Protein Methylation Profiling by Combined Chemical and Immunoaffinity Approaches Reveals Novel PRMT1 Targets.
Hartel NG; Chew B; Qin J; Xu J; Graham NA
Mol Cell Proteomics; 2019 Nov; 18(11):2149-2164. PubMed ID: 31451547
[TBL] [Abstract][Full Text] [Related]
7. Transcriptional repression of hypoxia-inducible factor-1 (HIF-1) by the protein arginine methyltransferase PRMT1.
Lafleur VN; Richard S; Richard DE
Mol Biol Cell; 2014 Mar; 25(6):925-35. PubMed ID: 24451260
[TBL] [Abstract][Full Text] [Related]
8. hCAF1, a new regulator of PRMT1-dependent arginine methylation.
Robin-Lespinasse Y; Sentis S; Kolytcheff C; Rostan MC; Corbo L; Le Romancer M
J Cell Sci; 2007 Feb; 120(Pt 4):638-47. PubMed ID: 17264152
[TBL] [Abstract][Full Text] [Related]
9. ID2 expression is not associated with MYCN amplification or expression in human neuroblastomas.
Wang Q; Hii G; Shusterman S; Mosse Y; Winter CL; Guo C; Zhao H; Rappaport E; Hogarty MD; Maris JM
Cancer Res; 2003 Apr; 63(7):1631-5. PubMed ID: 12670915
[TBL] [Abstract][Full Text] [Related]
10. Methylation of C/EBPα by PRMT1 Inhibits Its Tumor-Suppressive Function in Breast Cancer.
Liu LM; Sun WZ; Fan XZ; Xu YL; Cheng MB; Zhang Y
Cancer Res; 2019 Jun; 79(11):2865-2877. PubMed ID: 31015230
[TBL] [Abstract][Full Text] [Related]
11. PRMT1 expression is elevated in head and neck cancer and inhibition of protein arginine methylation by adenosine dialdehyde or PRMT1 knockdown downregulates proliferation and migration of oral cancer cells.
Chuang CY; Chang CP; Lee YJ; Lin WL; Chang WW; Wu JS; Cheng YW; Lee H; Li C
Oncol Rep; 2017 Aug; 38(2):1115-1123. PubMed ID: 28656289
[TBL] [Abstract][Full Text] [Related]
12. Methylation of RUNX1 by PRMT1 abrogates SIN3A binding and potentiates its transcriptional activity.
Zhao X; Jankovic V; Gural A; Huang G; Pardanani A; Menendez S; Zhang J; Dunne R; Xiao A; Erdjument-Bromage H; Allis CD; Tempst P; Nimer SD
Genes Dev; 2008 Mar; 22(5):640-53. PubMed ID: 18316480
[TBL] [Abstract][Full Text] [Related]
13. Substrate profiling of PRMT1 reveals amino acid sequences that extend beyond the "RGG" paradigm.
Wooderchak WL; Zang T; Zhou ZS; Acuña M; Tahara SM; Hevel JM
Biochemistry; 2008 Sep; 47(36):9456-66. PubMed ID: 18700728
[TBL] [Abstract][Full Text] [Related]
14. MCPIP1 Exogenous Overexpression Inhibits Pathways Regulating MYCN Oncoprotein Stability in Neuroblastoma.
Boratyn E; Nowak I; Durbas M; Horwacik I; Sawicka A; Rokita H
J Cell Biochem; 2017 Jul; 118(7):1741-1755. PubMed ID: 27935099
[TBL] [Abstract][Full Text] [Related]
15. Methylation by protein arginine methyltransferase 1 increases stability of Axin, a negative regulator of Wnt signaling.
Cha B; Kim W; Kim YK; Hwang BN; Park SY; Yoon JW; Park WS; Cho JW; Bedford MT; Jho EH
Oncogene; 2011 May; 30(20):2379-89. PubMed ID: 21242974
[TBL] [Abstract][Full Text] [Related]
16. The long non-coding RNA MYCNOS-01 regulates MYCN protein levels and affects growth of MYCN-amplified rhabdomyosarcoma and neuroblastoma cells.
O'Brien EM; Selfe JL; Martins AS; Walters ZS; Shipley JM
BMC Cancer; 2018 Feb; 18(1):217. PubMed ID: 29466962
[TBL] [Abstract][Full Text] [Related]
17. The role of protein arginine-methyltransferase 1 in gliomagenesis.
Wang S; Tan X; Yang B; Yin B; Yuan J; Qiang B; Peng X
BMB Rep; 2012 Aug; 45(8):470-5. PubMed ID: 22917032
[TBL] [Abstract][Full Text] [Related]
18. MYCN promotes neuroblastoma malignancy by establishing a regulatory circuit with transcription factor AP4.
Xue C; Yu DM; Gherardi S; Koach J; Milazzo G; Gamble L; Liu B; Valli E; Russell AJ; London WB; Liu T; Cheung BB; Marshall GM; Perini G; Haber M; Norris MD
Oncotarget; 2016 Aug; 7(34):54937-54951. PubMed ID: 27448979
[TBL] [Abstract][Full Text] [Related]
19. Protein Arginine Methyltransferase 1 Methylates Smurf2.
Cha B; Park Y; Hwang BN; Kim SY; Jho EH
Mol Cells; 2015 Aug; 38(8):723-8. PubMed ID: 26126536
[TBL] [Abstract][Full Text] [Related]
20. Arginine methylation of BCL-2 antagonist of cell death (BAD) counteracts its phosphorylation and inactivation by Akt.
Sakamaki J; Daitoku H; Ueno K; Hagiwara A; Yamagata K; Fukamizu A
Proc Natl Acad Sci U S A; 2011 Apr; 108(15):6085-90. PubMed ID: 21444773
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
